Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Organon logo — Here for her health

Organon

Here for her health

Founded 2020 United States Jersey City, United States 6946 employees Post Ipo Debt Total: $1.00B Health Care, Medical Devices +2

General Information

Company Name Organon
Founded Year 2020
Location United States Jersey City, United States +1
Founders / Decision Makers
Team member
Employees 6946
Industries Health Care, Medical Devices, Pharmaceutical +1
Funding Stage Post Ipo Debt
Social

Get notified when Organon moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Organon

Organon, founded in 2020 and headquartered in the United States, is a promising player in the global healthcare landscape. Driven by their mission 'Here for her health,' Organon specializes in women's health, biosimilars, and established medicines across a broad spectrum of conditions. The company's commitment to delivering impactful healthcare solutions positions it uniquely within the industry.

With a strategic focus on women’s health, the company is poised for growth in an expanding market that sees increasing demand for specialized healthcare products and services. Their robust portfolio reinforces their competitive edge in the Health Care, Medical Devices, Pharmaceutical, and Women's Health sectors.

Most recently, Organon secured a significant investment with a $1.00B Post-IPO Debt round on 07 May 2024, signifying strong investor confidence and providing essential capital to fuel further initiatives.

Taxonomy: Women's Health, Biosimilars, Established Medicines, Reproductive Health, Heart Disease, Dermatology, Allergies, Asthma, Pharmaceuticals, Healthcare Solutions, Therapies, Adverse Event Reporting, Recruitment Fraud Warning

Services & Products

Development and distribution of women's health therapies
General medicines franchise
Healthcare professional support programs
Research and development in women's health

Target Customers

Women at various life stages Healthcare professionals Patients with chronic and acute conditions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• - 07 May 2024

Organon Alternatives & Competitors

View All Alternatives
Organon vs
Curative
Curative United States

Building a healthier tomorrow, together.

Seed
1060 employees
Health Care, Health and Wellness
Compare Organon vs Curative
Organon vs
The Janssen Pharmaceutical Companies of Johnson & Johnson
The Janssen Pharmaceutical Companies of Johnson & Johnson United States

At Janssen, we never stop working toward a future where disease is a thing of the past. We’re the...

19627 employees
Biotechnology
Organon vs
Firefly Health
Firefly Health United States

Integrating care, coverage, and navigation to create an exceptional healthcare experience.

Series Unknown
121 employees
Health Care, Health and Wellness
Compare Organon vs Firefly Health
Also compare with: Organon vs Olema Oncology Olema Oncology View all alternatives

FAQ About Organon

Here for her health
Organon was founded in 2020.
Organon is headquartered in Jersey City, United States.
Organon operates in the following industries: Health Care, Medical Devices, Pharmaceutical, Women's Health.
Organon has approximately 6946 employees.
Organon has completed 1 funding round, raising a total of $1.00B. The latest funding stage is Post Ipo Debt.
Organon offers: Development and distribution of women's health therapies, General medicines franchise, Healthcare professional support programs, Research and development in women's health.
Top alternatives and competitors to Organon include Curative, The Janssen Pharmaceutical Companies of Johnson & Johnson, Firefly Health, Olema Oncology, Pfizer 21. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Organon and Curative are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Organon and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy